Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment
Therapeutics and Clinical Risk Management Oct 11, 2017
Hong H, et al. - The possibility and safety of alternatives to adenoidectomy with a 12-week treatment with nasal budesonide was researched in this study. Adenoid hypertrophy (AH) children who had improved after an initial 2-week budesonide therapy can achieve clinical improvements and reduce the frequency of adenoidectomy following the therapy with a 12-week treatment with nasal budesonide.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries